{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:05:52Z","timestamp":1771923952001,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.biopha.2021.112217","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T14:13:53Z","timestamp":1632233633000},"page":"112217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Urinary metabolomics of HCV patients with severe liver fibrosis before and during the sustained virologic response achieved by direct acting antiviral treatment"],"prefix":"10.1016","volume":"143","author":[{"given":"Elisa","family":"Biliotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ottavia","family":"Giampaoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Sciubba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Marini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberta","family":"Tomassini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Capuani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rozenn","family":"Esvan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Spaziante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Taliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Miccheli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112217_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Blach","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2021.112217_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"Thrift","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2021.112217_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2021.112217_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2021.112217_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.13673","article-title":"Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?","volume":"38","author":"Asselah","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2021.112217_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185728","article-title":"Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network","volume":"12","author":"Kondili","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.112217_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177352","article-title":"Improvement of ALT decay kinetics by all-oral HCV treatment: role of NS5A inhibitors and differences with IFN-based regimens","volume":"12","author":"Cento","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.112217_bib8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1053\/j.gastro.2018.10.033","article-title":"What are the benefits of a sustained virologic response to direct-acting antiviral therapy for hepatitis C virus infection?","volume":"156","author":"Ioannou","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2021.112217_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3748\/wjg.v22.i1.417","article-title":"Nuclear magnetic resonance based metabolomics and liver diseases: recent advances and future clinical applications","volume":"22","author":"Amathieu","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.112217_bib10","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.27264","article-title":"Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans","volume":"60","author":"Ladep","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.112217_bib11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2893.2009.01252.x","article-title":"Hepatitis C virus infection diagnosis using metabonomics","volume":"17","author":"Godoy","year":"2010","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.biopha.2021.112217_bib12","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.3748\/wjg.v23.i15.2685","article-title":"Changes in human hepatic metabolism in steatosis and cirrhosis","volume":"23","author":"Schofield","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.112217_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155094","article-title":"Metabolic characterization of advanced liver fibrosis in HCV patients as studied by serum 1H NMR spectroscopy","volume":"11","author":"Embade","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.112217_bib14","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.dld.2017.05.018","article-title":"Metabolomic analysis with 1H NMR for non-invasive diagnosis of hepatic fibrosis degree in patients with chronic hepatitis C","volume":"49","author":"Gabbani","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.biopha.2021.112217_bib15","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1038\/s41598-019-40028-4","article-title":"The metabolic fingerprints of HCV and HBV infections studied by Nuclear Magnetic Resonance Spectroscopy","volume":"9","author":"Meoni","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2021.112217_bib16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Cast\u00e9ra","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2021.112217_bib17","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3945\/jn.113.177105","article-title":"Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 induce different age-related metabolic profiles revealed by 1H NMR spectroscopy in urine and feces of mice","volume":"143","author":"Brasili","year":"2013","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2021.112217_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11306-011-0330-3","article-title":"Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies","volume":"8","author":"Szyma\u0144ska","year":"2012","journal-title":"Metabolomics"},{"key":"10.1016\/j.biopha.2021.112217_bib19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1158\/1055-9965.EPI-16-0366","article-title":"Metabolomic characterization of hepatocellular carcinoma in patients with liver cirrhosis for biomarker discovery","volume":"26","author":"Di Poto","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.biopha.2021.112217_bib20","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/hep.26130","article-title":"Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma","volume":"57","author":"Wang","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.112217_bib21","first-page":"647","article-title":"Interrelation between whole-body turnover rates of RNA and protein","volume":"44","author":"Sch\u00f6ch","year":"1990","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2021.112217_bib22","first-page":"697","article-title":"Pseudouridine for monitoring interferon treatment of patients with chronic hepatitis C","volume":"34","author":"Colonna","year":"1996","journal-title":"Eur. J. Clin. Chem. Clin. Biochem"},{"key":"10.1016\/j.biopha.2021.112217_bib23","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ijo.2015.40","article-title":"Urinary (1)H NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment","volume":"39","author":"Miccheli","year":"2015","journal-title":"Int J. Obes."},{"key":"10.1016\/j.biopha.2021.112217_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1743-422X-10-251","article-title":"Oxidative stress and hepatitis C virus","volume":"10","author":"Paracha","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.biopha.2021.112217_bib25","first-page":"200","article-title":"Oxidative stress in alcoholic liver disease","volume":"110","author":"Nalini","year":"1999","journal-title":"Indian J. Med Res."},{"key":"10.1016\/j.biopha.2021.112217_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2021.04.005","article-title":"Hepatic accumulation of hypoxanthine: a link between hyperuricemia and nonalcoholic fatty liver disease","author":"Toledo-Ibelles","year":"2021","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.biopha.2021.112217_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000186376","article-title":"Production of methylguanidine from creatinine via creatol by active oxygen species: analyses of the catabolism in vitro","volume":"58","author":"Nakamura","year":"1991","journal-title":"Nephron"},{"key":"10.1016\/j.biopha.2021.112217_bib28","first-page":"S229","article-title":"Role of active oxygen on methylguanidine synthesis in isolated rat hepatocytes","volume":"22","author":"Aoyagi","year":"1987","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.biopha.2021.112217_bib29","first-page":"82","article-title":"Biosynthesis of methylguanidine in the hepatic peroxisomes and the effect of the induction of peroxisomal enzymes by clofibrate","volume":"78","author":"Takemura","year":"1998","journal-title":"NEF"},{"key":"10.1016\/j.biopha.2021.112217_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm1543","article-title":"Disruption of methylarginine metabolism impairs vascular homeostasis","volume":"13","author":"Leiper","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2021.112217_bib31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.metabol.2011.08.007","article-title":"Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness","volume":"61","author":"Davids","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2021.112217_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1258\/acb.2009.009196","article-title":"The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine","volume":"47","author":"Blackwell","year":"2010","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.biopha.2021.112217_bib33","doi-asserted-by":"crossref","first-page":"9466","DOI":"10.3748\/wjg.v21.i32.9466","article-title":"Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis","volume":"21","author":"Lluch","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.112217_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4254\/wjh.v7.i3.443","article-title":"Endothelial dysfunction in cirrhosis: role of inflammation and oxidative stress","volume":"7","author":"Vairappan","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.biopha.2021.112217_bib35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2362.2007.01814.x","article-title":"ADMA correlates with portal pressure in patients with compensated cirrhosis","volume":"37","author":"Vizzutti","year":"2007","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.biopha.2021.112217_bib36","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/hep.20241","article-title":"Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma","volume":"39","author":"J\u00fcngst","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.112217_bib37","doi-asserted-by":"crossref","first-page":"1579S","DOI":"10.1093\/jn\/137.6.1579S","article-title":"Aromatic amino acid metabolism during liver failure","volume":"137","author":"Dejong","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2021.112217_bib38","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.24412","article-title":"Branched-chain amino acids as pharmacological nutrients in chronic liver disease","volume":"54","author":"Kawaguchi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.112217_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nut.2014.03.016","article-title":"Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy","volume":"31","author":"Holecek","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/j.biopha.2021.112217_bib40","series-title":"Textbook of Biochemistry with Clinical Correlations","author":"Devlin","year":"2010"},{"key":"10.1016\/j.biopha.2021.112217_bib41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ijc.29718","article-title":"Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: findings from a prospective cohort study","volume":"138","author":"Stepien","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2021.112217_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159205","article-title":"Plasma amino acid concentrations predict mortality in patients with end-stage liver disease","volume":"11","author":"Kinny-K\u00f6ster","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.112217_bib43","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.cgh.2013.08.050","article-title":"Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis","volume":"12","author":"Kawaguchi","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2021.112217_bib44","doi-asserted-by":"crossref","first-page":"79480","DOI":"10.18632\/oncotarget.18447","article-title":"Evaluation of the branched-chain amino acid-to-tyrosine ratio prior to treatment as a prognostic predictor in patients with liver cirrhosis","volume":"8","author":"Ishikawa","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2021.112217_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mehy.2018.02.010","article-title":"Ammonia:a novel target for the treatment of non-alcoholic steatohepatitis","volume":"113","author":"Thomsen","year":"2018","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.biopha.2021.112217_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104809","article-title":"Novel aspects of glutamine synthetase in ammonia homeostasis","volume":"140","author":"Zhou","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2021.112217_bib47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0168-8278(05)80480-5","article-title":"Nicotinamide methylation in patients with cirrhosis","volume":"20","author":"Cuomo","year":"1994","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2021.112217_bib48","doi-asserted-by":"crossref","first-page":"14835","DOI":"10.1016\/S0021-9258(17)36700-5","article-title":"Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization","volume":"269","author":"Aksoy","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2021.112217_bib49","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tem.2017.02.004","article-title":"Nicotinamide N-methyltransferase: more than a vitamin B3 clearance\u00a0enzyme","volume":"28","author":"Pissios","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2021.112217_bib50","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.3882","article-title":"Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization","volume":"21","author":"Hong","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2021.112217_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2007-1007107","article-title":"Cytokines in viral hepatitis","volume":"19","author":"Koziel","year":"1999","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.biopha.2021.112217_bib52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0168-8278(99)80060-9","article-title":"Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity","volume":"30","author":"Zylberberg","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2021.112217_bib53","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.clinre.2018.11.014","article-title":"Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease","volume":"43","author":"Wang","year":"2019","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.biopha.2021.112217_bib54","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1023\/A:1018804426724","article-title":"Activation of tumor necrosis factor-\u03b1 system in chronic hepatitis C virus infection","volume":"42","author":"Nelson","year":"1997","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2021.112217_bib55","series-title":"Branched Chain Amino Acids in Clinical Nutrition: Volume 1","year":"2015"},{"key":"10.1016\/j.biopha.2021.112217_bib56","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/s40064-015-1304-0","article-title":"Simultaneous quantification of salivary 3-hydroxybutyrate, 3-hydroxyisobutyrate, 3-hydroxy-3-methylbutyrate, and 2-hydroxybutyrate as possible markers of amino acid and fatty acid catabolic pathways by LC\u2013ESI\u2013MS\/MS","volume":"4","author":"Miyazaki","year":"2015","journal-title":"SpringerPlus"},{"key":"10.1016\/j.biopha.2021.112217_bib57","first-page":"37","article-title":"Beta-hydroxy-beta-methylbutyrate and sarcopenia: from biological plausibility to clinical evidence","volume":"22","author":"Landi","year":"2019","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.biopha.2021.112217_bib58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbrc.2003.07.016","article-title":"Branched-chain amino acids as a protein- and energy-source in liver cirrhosis","volume":"313","author":"Moriwaki","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2021.112217_bib59","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ymgme.2015.06.008","article-title":"Metabolite studies in HIBCH and ECHS1 defects: implications for screening","volume":"115","author":"Peters","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.biopha.2021.112217_bib60","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/hep.510240614","article-title":"The valine catabolic pathway in human liver: effect of cirrhosis on enzyme activities","volume":"24","author":"Taniguchi","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.112217_bib61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbrc.2003.07.022","article-title":"Effects of liver failure on the enzymes in the branched-chain amino acid catabolic pathway","volume":"313","author":"Shimomura","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2021.112217_bib62","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/ajmg.a.38658","article-title":"Clinical, biochemical, and genetic features of four patients with short-chain enoyl-CoA hydratase (ECHS1) deficiency","volume":"176","author":"Fitzsimons","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.biopha.2021.112217_bib63","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1665-2681(19)31355-9","article-title":"S-adenosylmethionine metabolism and liver disease","volume":"12","author":"Mato","year":"2013","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.biopha.2021.112217_bib64","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2012.04.041","article-title":"S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility","volume":"57","author":"Anstee","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2021.112217_bib65","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1177\/153537020422901002","article-title":"DNA methylation, cancer susceptibility, and nutrient interactions","volume":"229","author":"Davis","year":"2004","journal-title":"Exp. Biol. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221010015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221010015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:08:09Z","timestamp":1771920489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221010015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":65,"alternative-id":["S0753332221010015"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112217","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary metabolomics of HCV patients with severe liver fibrosis before and during the sustained virologic response achieved by direct acting antiviral treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112217"}}